Literature DB >> 25829459

Axillary Lymphadenopathy: An Outstanding Presentation for Breast Implant-Associated ALK-Negative Anaplastic Large Cell Lymphoma.

Juan C Tardío1, Rosario Granados2.   

Abstract

Till date, there is only one reported case of breast implant-associated ALK-negative anaplastic large cell lymphoma (ALCL) with an axillary presentation that followed an aggressive behavior. We report the case of a 50-year-old female presenting with an axillary lymphadenopathy 8 years after breast prostheses implantation. Clinical examination, ultrasound, and magnetic resonance imaging detected no mammary lesions. The lymph node showed intrasinusoidal infiltration by large pleomorphic cells expressing CD30 and lacking ALK-immunoreactivity. Tumor staging was negative. Cells with identical features were found in the ipsilateral periprosthetic capsule. The patient was treated with CHOP and radiotherapy, and she is alive without evidence of disease after a 30-month follow-up. The diagnosis of an ALK-negative ALCL in an axillary lymph node of a patient with ipsilateral breast prosthesis and negative staging should prompt removal of the implant with capsulectomy, since the pathological study of this specimen allows the correct diagnosis with important prognostic implications.
© The Author(s) 2015.

Entities:  

Keywords:  ALK-negative anaplastic large cell lymphoma; breast implant–associated anaplastic large cell lymphoma; breast lymphoma; silicone gel prosthesis

Mesh:

Substances:

Year:  2015        PMID: 25829459     DOI: 10.1177/1066896915579103

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  7 in total

Review 1.  Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management.

Authors:  Tessa L St Cyr; Barbara A Pockaj; Donald W Northfelt; Fiona E Craig; Mark W Clemens; Raman C Mahabir
Journal:  Plast Surg (Oakv)       Date:  2020-05-21       Impact factor: 0.947

2.  Analysis of Allergan's Biocell Implant Recall in a Major University Breast Center.

Authors:  Michel A Danino; Lan Dao; Meir Retchkiman; Edwige Matetsa; Jessica Iezzoni; Joseph S Bou-Merhi
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-06-25

Review 3.  Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  P Rastogi; A K Deva; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

4.  Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.

Authors:  Maria C Ferrufino-Schmidt; L Jeffrey Medeiros; Hui Liu; Mark W Clemens; Kelly K Hunt; Camille Laurent; Julian Lofts; Mitual B Amin; Siaw Ming Chai; Angela Morine; Arianna Di Napoli; Ahmet Dogan; Vinita Parkash; Govind Bhagat; Denise Tritz; Andres E Quesada; Sergio Pina-Oviedo; Qinlong Hu; Francisco J Garcia-Gomez; Juan Jose Borrero; Pedro Horna; Beenu Thakral; Marina Narbaitz; R Condon Hughes; Li-Jun Yang; Jonathan R Fromm; David Wu; Da Zhang; Aliyah R Sohani; John Hunt; Indira U Vadlamani; Elizabeth A Morgan; Judith A Ferry; Reka Szigeti; Juan C Tardio; Rosario Granados; Susanne Dertinger; Felix A Offner; Andreas Pircher; Jeff Hosry; Ken H Young; Roberto N Miranda
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

5.  Breast implant-associated anaplastic large cell lymphoma.

Authors:  Lindsay Keith; William Herlihy; Houston Holmes; Paul Pin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-10

6.  Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).

Authors:  Jun-Ho Lee
Journal:  Yeungnam Univ J Med       Date:  2021-01-19

7.  Breast Implant-Associated Anaplastic Large Cell Lymphoma: Case Report and Review of the Literature.

Authors:  Eva Berlin; Kunwar Singh; Christopher Mills; Ilan Shapira; Richard L Bakst; Manjeet Chadha
Journal:  Case Rep Hematol       Date:  2018-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.